论文部分内容阅读
AIM:To evaluate the safety and efficacy of combined pegylated interferon and ribavirin for the treatment of chronic hepatitis C(HCV)in patients with sickle cell anemia(SCA). METHODS:Fifty-two patients with SCA and HCV were treated over a period of 7 years